Marijuana and the Brain: Study Finds Memory and Decision-Making at Risk
This study highlights heavy cannabis use cognitive impairments, specifically in memory and decision-making. Clinicians can use this evidence to inform patients about risks to executive function. Understanding these effects supports better clinical…
Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis
This study examines the cannabis use disorder psychiatric risk profile compared to other substance use disorders. Findings indicate lower rates of schizophrenia, depression, and psychotic disorders in cannabis users. These insights inform clinical risk…
Mental Health Problems More Likely for Teen Cannabis Users
Adolescent cannabis mental health studies show increased psychiatric risks for teen cannabis users. These studies highlight the vulnerability of the developing brain to cannabis exposure. Clinicians should screen for cannabis use alongside mental health…
New ADAI Research: Cannabis-Related Problems and Clinical Experiences
New ADAI research highlights cannabis use disorder clinical education as crucial for healthcare providers. Many clinicians report feeling unprepared to manage cannabis-related problems effectively. This study emphasizes the need for enhanced provider…
PTTC Brief 02: Environmental Strategies to Prevent Cannabis Misuse and Related Harms
Environmental cannabis prevention strategies offer population-level interventions to reduce cannabis misuse and related harms. These approaches complement clinical care by addressing policy and community factors. Understanding these strategies helps…
Cannabis Use Disorder Treatment Europe Review
CED Clinical Relevance #50 Monitored Relevance Early-stage or contextual signal requiring further evidence before action. Clinical Insight | CED Clinic Evidence Watch Cannabis Use Disorder Europe Mental Health Audience Patients, caregivers,…
Aelis Farma Reports Its 2025 Annual Financial Results and Confirms Its 2026 Outlook
Aelis Farma announced its financial results for 2025, highlighting progress in cannabis use disorder treatment development. The 2026 outlook confirms continued clinical trial advancements. This report focuses on Aelis Farma financial results 2025 and…
Relationally anchored motivation in alcohol and cannabis use disorder: a clinical case analysis
This case analysis highlights relational motivation substance use recovery in patients with co-occurring alcohol and cannabis use disorders. Interpersonal relationships serve as key motivational anchors supporting recovery efforts. Understanding these…
Medically Recommended Cannabis Use for US Adolescents.
This study examines medically recommended cannabis use adolescents using nationally representative data. It reveals 5.2% of adolescent cannabis users have medical recommendations. Understanding medically recommended cannabis use adolescents informs…
Most European Countries Lack Evidence-Based Cannabis-Specific Treatment
Cannabis-specific treatment programs Europe remain limited and often lack evidence-based approaches. This 2025 overview reveals fragmented services with insufficient coverage. Structured psychosocial interventions are the most supported treatments for…
